TCI Wealth Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.88M | Buy |
15,431
+268
| +2% | +$57.7K | 0.17% | 52 |
|
|
2026
Q1 | $3.3M | Sell |
15,163
-112
| -0.7% | -$24.8K | 0.18% | 55 |
|
|
2025
Q4 | $3.49M | Sell |
15,275
-93
| -0.6% | -$21.2K | 0.19% | 55 |
|
|
2025
Q3 | $3.56M | Buy |
15,368
+138
| +0.9% | +$28.1K | 0.21% | 51 |
|
|
2025
Q2 | $2.83M | Sell |
15,230
-46
| -0.3% | -$8.55K | 0.19% | 54 |
|
|
2025
Q1 | $3.2M | Sell |
15,276
-1,106
| -7% | -$215K | 0.26% | 40 |
|
|
2024
Q4 | $2.91M | Buy |
16,382
+97
| +0.6% | +$17.8K | 0.24% | 40 |
|
|
2024
Q3 | $3.22M | Sell |
16,285
-83
| -0.5% | -$15.5K | 0.27% | 40 |
|
|
2024
Q2 | $2.81M | Sell |
16,368
-11
| -0.1% | -$1.82K | 0.26% | 42 |
|
|
2024
Q1 | $2.98M | Sell |
16,379
-664
| -4% | -$114K | 0.29% | 40 |
|
|
2023
Q4 | $2.64M | Buy |
17,043
+165
| +1% | +$24.1K | 0.28% | 39 |
|
|
2023
Q3 | $2.52M | Buy |
16,878
+416
| +3% | +$61.1K | 0.32% | 36 |
|
|
2023
Q2 | $2.22M | Buy |
16,462
+18
| +0.1% | +$2.64K | 0.28% | 40 |
|
|
2023
Q1 | $2.62M | Sell |
16,444
-304
| -2% | -$46.5K | 0.34% | 34 |
|
|
2022
Q4 | $2.71M | Sell |
16,748
-27
| -0.2% | -$4.14K | 0.37% | 33 |
|
|
2022
Q3 | $2.25M | Buy |
16,775
+142
| +0.9% | +$20.4K | 0.36% | 32 |
|
|
2022
Q2 | $2.55M | Buy |
16,633
+218
| +1% | +$33.3K | 0.39% | 31 |
|
|
2022
Q1 | $2.66M | Buy |
16,415
+517
| +3% | +$75.1K | 0.4% | 26 |
|
|
2021
Q4 | $2.15M | Sell |
15,898
-198
| -1% | -$23.4K | 0.32% | 36 |
|
|
2021
Q3 | $1.74M | Sell |
16,096
-1,352
| -8% | -$154K | 0.26% | 41 |
|
|
2021
Q2 | $1.97M | Buy |
17,448
+1,109
| +7% | +$125K | 0.33% | 34 |
|
|
2021
Q1 | $1.77M | Buy |
16,339
+110
| +0.7% | +$11.8K | 0.75% | 28 |
|
|
2020
Q4 | $1.74M | Sell |
16,229
-2,961
| -15% | -$285K | 0.78% | 26 |
|
|
2020
Q3 | $1.68M | Buy |
19,190
+668
| +4% | +$62.9K | 0.66% | 30 |
|
|
2020
Q2 | $1.82M | Sell |
18,522
-6
| -0% | -$528 | 0.78% | 28 |
|
|
2020
Q1 | $1.41M | Sell |
18,528
-967
| -5% | -$82.4K | 0.7% | 33 |
|
|
2019
Q4 | $1.73M | Sell |
19,495
-1,400
| -7% | -$116K | 0.67% | 36 |
|
|
2019
Q3 | $1.58M | Buy |
20,895
+2,200
| +12% | +$151K | 0.7% | 37 |
|
|
2019
Q2 | $1.36M | Sell |
18,695
-76
| -0.4% | -$5.97K | 0.61% | 41 |
|
|
2019
Q1 | $1.51M | Sell |
18,771
-48
| -0.3% | -$3.93K | 0.67% | 39 |
|
|
2018
Q4 | $1.74M | Sell |
18,819
-722
| -4% | -$63.5K | 0.84% | 31 |
|
|
2018
Q3 | $1.85M | Buy |
19,541
+78
| +0.4% | +$7.4K | 0.77% | 34 |
|
|
2018
Q2 | $1.8M | Buy |
19,463
+24
| +0.1% | +$2.34K | 0.8% | 33 |
|
|
2018
Q1 | $1.84M | Sell |
19,439
-264
| -1% | -$29K | 0.85% | 27 |
|
|
2017
Q4 | $1.91M | Buy |
19,703
+600
| +3% | +$56.5K | 0.84% | 27 |
|
|
2017
Q3 | $1.7M | Buy |
19,103
+813
| +4% | +$61.9K | 0.83% | 30 |
|
|
2017
Q2 | $1.33M | Sell |
18,290
-246
| -1% | -$16.5K | 0.68% | 38 |
|
|
2017
Q1 | $1.21M | Sell |
18,536
-1,384
| -7% | -$87K | 0.63% | 41 |
|
|
2016
Q4 | $1.25M | Buy |
19,920
+14
| +0.1% | +$855 | 0.65% | 39 |
|
|
2016
Q3 | $1.25M | Buy |
19,906
+13
| +0.1% | +$842 | 0.68% | 36 |
|
|
2016
Q2 | $1.23M | Buy |
19,893
+571
| +3% | +$34.8K | 0.68% | 36 |
|
|
2016
Q1 | $1.1M | Buy |
19,322
+1,577
| +9% | +$87.9K | 0.61% | 41 |
|
|
2015
Q4 | $1.05M | Buy |
17,745
+101
| +0.6% | +$5.82K | 0.59% | 45 |
|
|
2015
Q3 | $960K | Sell |
17,644
-1,851
| -9% | -$120K | 0.58% | 44 |
|
|
2015
Q2 | $1.31M | Buy |
19,495
+269
| +1% | +$17.6K | 0.75% | 36 |
|
|
2015
Q1 | $1.13M | Sell |
19,226
-277
| -1% | -$16.7K | 0.71% | 37 |
|
|
2014
Q4 | $1.28M | Buy |
19,503
+1,163
| +6% | +$73.3K | 0.79% | 35 |
|
|
2014
Q3 | $1.06M | Hold |
18,340
| – | – | 0.67% | 38 |
|
|
2014
Q2 | $1.03M | Hold |
18,340
| – | – | 0.62% | 40 |
|
|
2014
Q1 | $942K | Hold |
18,340
| – | – | 0.61% | 39 |
|
|
2013
Q4 | $969K | Sell |
18,340
-1,900
| -9% | -$93.4K | 0.61% | 38 |
|
|
2013
Q3 | $905K | Sell |
20,240
-600
| -3% | -$26.6K | 0.69% | 37 |
|
|
2013
Q2 | $862K | Buy |
+20,840
| New | +$911K | 0.65% | 37 |
|
Other funds holding ABBV
ECSS
ATO
TCI Wealth Advisors's ABBV Position: Q2 2026 in Review
TCI Wealth Advisors increased its AbbVie (ABBV) stake by 1.8% in Q2 2026, buying an estimated $57.7K and bringing the position to 15,431 shares worth $3.88M. The position accounts for 0.17% of the portfolio, ranked #52.
TCI Wealth Advisors first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- TCI Wealth Advisors held 15,431 shares of AbbVie worth $3.88M as of Q2 2026.
- TCI Wealth Advisors bought 268 AbbVie shares in Q2 2026, an estimated $57.7K.
- AbbVie made up 0.17% of TCI Wealth Advisors's portfolio in Q2 2026, its #52 holding.
- TCI Wealth Advisors first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on TCI Wealth Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.